Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium - PubMed (original) (raw)

Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium

N Barker et al. Am J Pathol. 1999 Jan.

Abstract

Tcf-4 is a member of the Tcf/Lef family of transcription factors that interact functionally with beta-catenin to mediate Wnt signaling in vertebrates. We have previously demonstrated that the tumor suppressor function of APC in the small intestine is mediated via regulation of Tcf-4/beta-catenin transcriptional activity. To gain further insight into the role of Tcf-4 in development and carcinogenesis we have generated several mouse monoclonal antibodies, one of which is specific for Tcf-4 and another of which recognizes both Tcf-3 and Tcf-4. Immunohistochemistry performed with the Tcf 4- specific monoclonal antibody revealed high levels of expression in normal intestinal and mammary epithelium and carcinomas derived therefrom. Additional sites of Tcf-3 expression, as revealed by staining with the Tcf-3/-4 antibody, occurred only within the stomach epithelium, hair follicles, and keratinocytes of the skin. A temporal Tcf-4 expression gradient was observed along the crypt-villus axis of human small intestinal epithelium: strong Tcf-4 expression was present within the crypts of early (week 16) human fetal small intestine, with the villi showing barely detectable Tcf-4 protein levels. Tcf-4 expression levels increased dramatically on the villi of more highly developed (week 22) fetal small intestine. We conclude that Tcf-4 exhibits a highly restricted expression pattern related to the developmental stage of the intestinal epithelium. The high levels of Tcf-4 expression in mammary epithelium and mammary carcinomas may also indicate a role in the development of this tissue and breast carcinoma.

PubMed Disclaimer

Figures

Figure 1.

Figure 1.

Immunohistochemical staining of hTcf-4 and mTcf-3 in COS cells using the 6H5 and 6F12 mAbs. a: Staining of COS cells expressing hTcf-4 (arrows) by the 6H5 mAb. b: Absence of staining on COS cells expressing mTcf-3 by the 6H5 mAb. Magnification, ×200. c,d: Staining of COS cells expressing hTcf-4 or mTcf-3 (arrows) by the 6F12 mAb. Magnification, ×200.

Figure 2.

Figure 2.

Immunohistochemical analysis of Tcf-4 and Tcf-3 expression in human and mouse tissues. a-h: Immunohistochemical stainings generated using the Tcf-4 specific mAb (6H5). i-j: Immunohistochemical stainings generated using the Tcf-3/−4 mAb (6F12). a,b: Tcf-4 is highly expressed at the tops of the crypts (arrows) of human adult colonic epithelium (a) and human colon carcinoma (b). Magnification, ×150. c,d: Tcf-4 is expressed at high levels in the fibrous tissue (open arrows) and crypts (shaded arrows) of human (c) and mouse (d) adult small intestinal epithelium. Magnification, ×100. e,f: Tcf-4 expression increases along the crypt-villus axis (arrows) during week 16 (e) and week 22 (f) of the development of human small intestinal epithelium. Magnification, ×50. g,h: Tcf-4 is expressed at high levels in the epithelium (shaded arrows) and fibrous tissue (open arrows) of human mammary gland (g) and mammary carcinoma (h). Magnification, ×100. i-j: Tcf-3 is expressed in hair follicles (i) and keratinocytes of skin (j). Magnification, ×100.

Figure 3.

Figure 3.

a: Gel retardation of Tcf-4 complexes from HT-29 colon carcinoma cells. Tcf-4 complexed to an optimal Tcf binding site probe can be supershifted by addition of the Tcf-4-specific mAb 6H5. Lane 1: Nonspecific (NS) bands generated using a probe comprising a disrupted Tcf binding site. Lane 2 : Specific Tcf-4/probe complex. Lane 3: Supershift of the Tcf-4/probe complex by addition of 6H5 mAb. Lane 4: Supershift of the Tcf-4/probe complex on addition of 6F12 mAb. Lanes 5 and 6: No supershift of the Tcf-4/probe complex induced on addition of control antibodies (anti-APC and anti-Plakoglobin). b: Co-immunoprecipitation of Tcf-4 and β-catenin from SW620 nuclear extracts. Lane 1: A 92-kd band (arrow) visualized by Western blot using an anti-β-catenin mAb after Tcf-4 immunoprecipitation from SW620 nuclear extracts using the 6H5 mAb. H, antibody heavy chain; L, antibody light chain. Lane 2: Western blot analysis of total β-catenin (arrow) in SW620 total cell extracts.

Similar articles

Cited by

References

    1. Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, Korinek V, Roose J, Destree O, Clevers H: Xtcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell 1996, 86:391-399 - PubMed
    1. Riese J, Yu X, Munnerlyn A, Eresh S, Hsu SC, Grosschedl R, Bienz M: LEF-1, a nuclear factor coordinating signaling inputs from wingless and decapentaplegic. Cell 1997, 88:777-787 - PubMed
    1. Brunner E, Peter O, Schweizer L, Basler K: Pangolin encodes a Lef-1 homologue that acts downstream of Armadillo to transduce the Wingless signal in Drosophila. Nature 1997, 385:829-833 - PubMed
    1. van de Wetering M, Cavallo R, Dooijes D, van Beest M, van Es J, Loureiro A, Ypma D, Hursh D, Jones T, Bejsovec A, Peifer M, Mortin M, Clevers H: Armadillo co-activates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 1997, 88:789-799 - PubMed
    1. Behrens J, van Kries JP, Kuehl M, Bruhn D, Wedlich R, Grosschedl R, Birchmeier W: Functional interaction of β-catenin with the transcription factor LEF-1. Nature 1996, 382:638-642 - PubMed

MeSH terms

Substances

LinkOut - more resources